Growing community of inventors

Santa Monica, CA, United States of America

Xiuqing Guo

Average Co-Inventor Count = 6.91

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Xiuqing GuoJerome I Rotter (3 patents)Xiuqing GuoKent D Taylor (3 patents)Xiuqing GuoHuiying Yang (2 patents)Xiuqing GuoMark O Goodarzi (2 patents)Xiuqing GuoWilla A Hsueh (2 patents)Xiuqing GuoLeslie J Raffel (2 patents)Xiuqing GuoStephan R Targan (1 patent)Xiuqing GuoDermot McGovern (1 patent)Xiuqing GuoYii-Der Ida Chen (1 patent)Xiuqing GuoTalin Haritunians (1 patent)Xiuqing GuoXiuqing Guo (3 patents)Jerome I RotterJerome I Rotter (27 patents)Kent D TaylorKent D Taylor (15 patents)Huiying YangHuiying Yang (15 patents)Mark O GoodarziMark O Goodarzi (2 patents)Willa A HsuehWilla A Hsueh (2 patents)Leslie J RaffelLeslie J Raffel (2 patents)Stephan R TarganStephan R Targan (50 patents)Dermot McGovernDermot McGovern (8 patents)Yii-Der Ida ChenYii-Der Ida Chen (2 patents)Talin HarituniansTalin Haritunians (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cedars-sinai Medical Center (3 from 596 patents)

2. University of California (1 from 15,458 patents)


3 patents:

1. 9580752 - Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy

2. 8178294 - Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes

3. 7141373 - Method of haplotype-based genetic analysis for determining risk for developing insulin resistance and coronary artery disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…